Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genpact (G) Cash & Equivalents (2016 - 2025)

Genpact has reported Cash & Equivalents over the past 17 years, most recently at $853.8 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $853.8 million for Q4 2025, up 31.71% from a year ago — trailing twelve months through Dec 2025 was $853.8 million (up 31.71% YoY), and the annual figure for FY2025 was $853.8 million, up 31.71%.
  • Cash & Equivalents for Q4 2025 was $853.8 million at Genpact, up from $740.8 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for G hit a ceiling of $1.0 billion in Q3 2024 and a floor of $460.4 million in Q2 2022.
  • Median Cash & Equivalents over the past 5 years was $647.5 million (2022), compared with a mean of $687.9 million.
  • Biggest five-year swings in Cash & Equivalents: tumbled 43.77% in 2022 and later surged 89.03% in 2024.
  • Genpact's Cash & Equivalents stood at $899.5 million in 2021, then dropped by 28.09% to $646.8 million in 2022, then decreased by 9.76% to $583.7 million in 2023, then increased by 11.06% to $648.2 million in 2024, then surged by 31.71% to $853.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $853.8 million (Q4 2025), $740.8 million (Q3 2025), and $663.3 million (Q2 2025) per Business Quant data.